scholarly journals Gut Microbiota and Body Weight – A Review

2018 ◽  
Vol 27 (1) ◽  
pp. 33-53
Author(s):  
Ioana Duca ◽  
Dan Lucian Dumitrescu

La relación entre la microbioma intestinal y la resistencia a la insulina tiene un impacto clínico importante dado que la gente afectada por disbiosis tiene predisposiciones para desarrollar la obesidad, la diabetes mellitus tipo 2, la enfermedad de hígado graso no alcohólico, cánceres, enfermedades cardiovasculares, neurodegenerativas y psiquiátricas. La disbiosis puede convertirse en una inflamación crónica, obesidad o síndrome metabólico. Hemos hecho una revisión sistemática de los estudios dedicados al papel de la microbioma intestinal para el aumento de peso y la obesidad. Una búsqueda sistemática de datos recientes publicados en las bases de datos electrónicas se ha llevado a cabo usando la frase “gut microbiome and body weight and obesity”. Se ha excluido a los estudios que no contenían informaciones sobre la influencia de los cambios de la microbioma intestinal en la obesidad. La dieta occidental, uso de los antibióticos en la niñez, peso excesivo antes del embarazo, parto por cesárea y deficiencia de testosterona provocan la alteración de la microbioma y por consiguiente la apariencia de la obesidad. El predominio de firmicutes y géneros anaeróbicos, cambios en el microbioma y populación intestinal viral están implícitos en la etiología de la obesidad. Prebióticos, polifenoles, diferentes hierbas, medicamentos (antidiabéticos, calcio), ejercicio físico, consumo de fibras y cirugía bariátrica son las opciones terapéuticas más importantes. Tratamientos dietéticos personalizados, agentes antivirales y manipulación de la microbioma representarían nuevas metas en el tratamiento de la obesidad. Cada cambio en la composición cuantitativa o cualitativa de la microbioma influye en los componentes del síndrome metabólico, así que todas las estrategias para el tratamiento o prevención de la obesidad en niños o adultos deberían tener microbioma como su meta.

2021 ◽  
Vol 6 (1) ◽  
Author(s):  
Juan Manuel Muñoz-Cano ◽  
Paula Sofía Pérez Muñoz

Introducción. La industria del azúcar se ha opuesto a aceptar que sus productos pueden ser la causa raíz principal de la pandemia de enfermedades no transmisibles. Objetivo. Analizar las bases que sustentan las posiciones acerca de limitar el consumo de fructosa que se agrega a bebidas y alimentos industrializados mediante la identificación de conceptos principales en artículos de revisión. Método. Se hizo una búsqueda en PUBMED con los términos ("fructose"[MeSH Terms] OR "fructose"[All Fields]) AND ("diabetes mellitus"[MeSH Terms] OR ("diabetes"[All Fields] AND "mellitus"[All Fields]) OR "diabetes mellitus"[All Fields]) AND ("review"[Publication Type] OR "review literature as topic"[MeSH Terms] OR "review"[All Fields]). Resultados. Se analizaron las consecuencias del consumo de la fructosa en enfermedades no transmisibles como obesidad, resistencia a la insulina, hígado graso, síndrome metabólico, envejecimiento prematuro, hiperuricemia, hipertensión, diabetes, daño renal, enfermedad cardiovascular. Sin aportar datos a favor de la inocuidad de la fructosa agregada a bebidas y alimentos, los autores con conflicto de interés, quienes reciben aportes de la industria del azúcar, desacreditan esos resultados mediante la construcción de falacias. Conclusiones. Las revisiones sistemáticas cuantitativas de autores con conflicto de interés sirven para sustentar posiciones escépticas y poco éticas hacia la evidencia científica.Palabras clave: Enfermedades no transmisibles; Conflicto de interés; Industria de alimentos y bebidas; Revisiones sistemáticas; Falacias.


2021 ◽  
Author(s):  
Rocío Mateo-Gallego ◽  
Isabel Moreno-Indias ◽  
Ana M. Bea ◽  
Lidia Sánchez-Alcoholado ◽  
Antonio J. Fumanal ◽  
...  

An alcohol-free beer including the substitution of regular carbohydrates for low doses of isomaltulose and maltodextrin within meals significantly impacts gut microbiota in diabetic subjects with overweight or obesity.


2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
A Kusamoto ◽  
M Harada ◽  
J M Azhary ◽  
C Kunitomi ◽  
E Nose ◽  
...  

Abstract Study question From when do abnormality in gut microbiome and phenotypes of PCOS appear during the process of growth? Summary answer Reproductive phenotypes of PCOS appear from 6 weeks and metabolic phenotypes from 12 weeks onward. Alteration in gut microbiome appears as early as 4 weeks. What is known already The etiology of PCOS remains largely unknown, however PCOS is considered as a complex multigenic disorder with strong epigenetic and environmental influence. Previous studies have suggested that fetal over-exposure to androgens could be the main factor of the development of PCOS after birth. On the other hands, recent studies on both human and PCOS rodent models have demonstrated the association between PCOS and alteration of gut microbiome in adulthood. Furthermore, it was recently reported that gut microbiome in obese adolescent with PCOS is different from obese adolescent without PCOS. Study design, size, duration A rodent PCOS model induced by prenatal dehydroepiandrosterone (DHT) exposure was applied to this study. Phenotypes and gut microbiome were compared between PCOS model mice (n = 12/group) and control mice (n = 10/group) at each stage of growth; 4 weeks (prepuberty), 6 weeks (puberty), 8 weeks (adolescent), 12 weeks (young adult), and 16 weeks (adult). The determinants for PCOS phenotypes are onset of puberty, estrous cycle, morphology of ovaries, serum testosterone level, body weight, and insulin resistance. Participants/materials, setting, methods Pregnant dams were subcutaneously injected on days of 16, 17, and 18 of gestation with either sesame oil for control groups or sesame oil containing 250µg of DHT for prenatal DHT groups. The evaluation of PCOS phenotypes and gut microbiome in female offspring were performed at each stage of growth. For examination of gut microbiota, next generation sequencing and bioinformatics analysis of 16S rRNA genes were performed on DNA extracted from mouse fecal samples. Main results and the role of chance Prenatal DHT mice exhibited delayed puberty onset, disrupted estrous cycle, and significantly increased testosterone levels from 6 weeks onward. Significantly increased atretic antral follicles were observed in prenatal DHT mice at 6, 12, and 16 weeks. Prenatal DHT mice showed significantly decreased body weight at 4, 6, 8 weeks and increased body weight from 12 weeks onward. As for gut microbiome, alpha-diversity was significantly different between control and prenatal DHT mice from 8 weeks onward and beta-diversity was significantly different at 6 and 8 weeks. Altered composition of gut microbiota was observed as early as 4 weeks. At phylum level, Firmicutes are significantly increased in prenatal DHT mice at 4 and 8 weeks and decreased at 16 weeks. Actinobacteria phylum showed significant decrease at 6 and 8 weeks in prenatal DHT mice. At genus level, relative abundance of several bacterial taxa significantly differed between control and prenatal DHT mice; some taxa, such as Allobaculum, Adlercreutzia, Bilophila, Clostridium, Gemella, Gemmiger, Roseburia, Ruminococcus, Staphylococcus, and Sutterella, exhibited constant increase or decrease in prenatal DHT mice during the process of growth. Interestingly, Roseburia was never detected in prenatal DHT mice, while approximately half of control mice harbored Roseburia at 12 and 16 weeks. Limitations, reasons for caution It is not clearly determined whether alteration in gut microbiome is cause or result of PCOS development, although the changes in gut microbiome seemed to precede the appearance of typical PCOS phenotypes in the present study. Mouse model does not completely recapitulate human PCOS. Wider implications of the findings: Our findings suggest that prenatal androgen exposure causes alteration of gut microbiome from pre-puberty onward, even before PCOS phenotypes become apparent. Intervention for girls at risk of PCOS with pre/pro-biotics may prevent them from developing PCOS in future. Trial registration number Not applicable


2019 ◽  
Vol 10 (11) ◽  
pp. 7063-7080 ◽  
Author(s):  
Suijuan Yue ◽  
Dan Zhao ◽  
Chunxiu Peng ◽  
Chao Tan ◽  
Qiuping Wang ◽  
...  

In a high sugar diet mode, TB reduced the body weight and TG and improved HOMA-IR mainly by targeting the gut microbiota. A strong correlation between cecal microorganisms and serum metabolites, obesity and HOMA-IR was observed.


2020 ◽  
Vol 41 (1) ◽  
pp. 47-57
Author(s):  
Deiby Susan Abasto Gonzales ◽  
Yercin Mamani Ortiz ◽  
Jenny Marcela Luizaga Lopez ◽  
Sandra Pacheco Luna ◽  
Daniel Elving Illanes Velarde

Introducción: el Síndrome Metabólico es un desorden complejo que incrementa el riego de desarrollar Diabetes Mellitus tipo 2 y Enfermedades cardiovasculares. Objetivo: analizar la prevalencia de factores de riesgo asociados al síndrome metabólico en conductores del transporte público en Cochabamba-Bolivia. Métodos: estudio observacional, analítico de corte transversal, en una población de referencia de N=246 conductores de 6 líneas de transporte de la zona sud de Cochabamba-Bolivia; alcanzando una muestra de n=69 sujetos de estudio y aplicando la metodología STEPS de la OPS/OMS. Se utilizó Chi cuadrado (X2) para la asociación estadística con el sexo; regresión logística bi-variada y multivariada para la obtención del OR crudo y ajustado en relación a los factores de riesgo asociados al SM. Resultados: las prevalencias de los factores de riesgo asociados a Síndrome Metabólico fueron: STEP-1: Tabaquismo 20,3%; consumo actual de alcohol 63,8%; bajo consumo de frutas y vegetales 94,2%; sedentarismo o bajo nivel de actividad física 66,7%. STEP-2: sobrepeso 47,8%; obesidad 37,7%; cintura de riesgo u obesidad abdominal 37,7% y presión arterial elevada en 36,4%. STEP3: Glicemia alterada en ayunas 43,9%; Resistencia a la Insulina 47,8%; colesterol total elevado 56,1%; Triglicéridos elevados 66,7% y HDL-colesterol reducido en el 60,6%. Conclusión: el síndrome metabólico es altamente prevalente en la población de conductores del transporte público de la zona sud de la ciudad de Cochabamba (79,3%); asociado al tiempo de trabajo en el rubro, el incremento de edad, la ausencia de pareja y la situación de trabajo.


2019 ◽  
Author(s):  
Kathleen E. Morrison ◽  
Eldin Jašarević ◽  
Christopher D. Howard ◽  
Tracy L. Bale

AbstractBackgroundDietary effects on the gut microbiome has been shown to play a key role in the pathophysiology of behavioral dysregulation, inflammatory disorders, metabolic syndrome, and obesity. Often overlooked is that experimental diets vary significantly in the proportion and source of dietary fiber. Commonly, treatment comparisons are made between animals that are fed refined diets that lack soluble fiber and animals fed vivarium-provided chow diet that contain a rich source of soluble fiber. Despite the well-established role of soluble fiber on metabolism, immunity, and behavior via the gut microbiome, the extent to which measured outcomes may be driven by differences in dietary fiber is unclear. Further, the significant impact of sex and age in response to dietary challenge is likely important and should also be considered.ResultsWe compared the impact of transitioning young and aged male and female mice from a chow diet to a refined low soluble fiber diet on body weight and gut microbiota. Then, to determine the contribution of dietary fat, we examined the impact of transitioning a subset of animals from refined low fat to refined high fat diet. Serial tracking of body weights revealed that consumption of low fat or high fat refined diet increased body weight in young and aged adult male mice. Young adult females showed resistance to body weight gain, while high fat diet-fed aged females had significant body weight gain. Transition from a chow diet to low soluble fiber refined diet accounted for most of the variance in community structure and composition across all groups. This dietary transition was characterized by a loss of taxa within the phylum Bacteroidetes and a concurrent bloom of Clostridia and Proteobacteria in a sex- and age-specific manner. Most notably, no changes to gut microbiota community structure and composition were observed between mice consuming either low- or high-fat diet, suggesting that transition to the refined diet that lacks soluble fiber is the primary driver of gut microbiota alterations, with limited additional impact of dietary fat on gut microbiota.ConclusionCollectively, our results show that the choice of control diet has a significant impact on outcomes and interpretation related to body weight and gut microbiota. These data also have broad implications for rodent studies that draw comparisons between refined high fat diets and chow diets to examine dietary fat effects on metabolic, immune, behavioral, and neurobiological outcomes.


2021 ◽  
Vol 12 ◽  
Author(s):  
Jingjing An ◽  
Junqi Wang ◽  
Li Guo ◽  
Yuan Xiao ◽  
Wenli Lu ◽  
...  

ObjectiveCatch-up growth (CUG) in small for gestational age (SGA) leads to increased risk of metabolic syndrome and cardiovascular diseases in adults. It remains unclear if microbiota could play an important role in CUG-SGA independent of genetic or nutritional factors. The present study explored the role of gut microbiota in, and its association with, metabolic disorders during CUG-SGA.MethodsAn SGA rat model was established by restricting food intake during pregnancy, and the rats were divided into catch-up growth (CUG-SGA) and non-catch-up growth (NCUG-SGA) groups based on body weight and length at the fourth postnatal week. High-throughput sequencing of 16S rRNA was conducted to detect the diversity and composition of the gut microbiota. Fecal short-chain fatty acids (SCFAs) were detected by gas chromatography-mass spectrometry. Transcriptome sequencing of liver tissue was performed and verified using real-time PCR. Concentrations of insulin and total cholesterol were determined using enzyme-linked immunosorbent assay.ResultsThe composition of gut microbiota in CUG-SGA rats differed from that of NCUG-SGA rats, with reduced abundance of Lactobacillus in the CUG-SGA group. The decrease in Lactobacillus was significantly associated with increased body weight and upregulated insulin and total cholesterol levels. Five SCFAs and two branched chain fatty acids were significantly higher in the CUG-SGA group than in the NCUG-SGA group. Additionally, SCFAs were positively associated with clinical indices such as weight, body mass index, insulin, and total cholesterol. Transcriptomic data revealed that insulin-like growth factor-2 expression was significantly decreased in CUG-SGA rats and was associated with a decrease in Lactobacillus bacteria.ConclusionLactobacillus and SCFAs were associated with the metabolic disorders during CUG in SGA. Gut microbiome may play a certain role on metabolic disorders during catch-up growth in small-for-gestational-age.


Revista Vive ◽  
2021 ◽  
Vol 4 (11) ◽  
pp. 173-192
Author(s):  
Jessica Valverde Pulla ◽  
Carem Prieto Fuentemayor

La obesidad infantil contribuye a la presencia de Resistencia a la Insulina (IR), lo que a su vez incrementa el riesgo de padecer alteraciones endocrino-metabólicas en la niñez. El HOMA-IR ha demostrado tener gran utilidad para la detección y seguimiento de estas patologías, sin embargo, se deben considerar las variables fisiológicas y patológicas a las que está sujeto su cálculo. Además tiene una buena correlación con el clamp euglucémico para la detección de IR, pero es indispensable marcar puntos de corte específicos para diagnosticar e identificar a los pacientes pediátricos con alto riesgo de Síndrome Metabólico y Diabetes 2, lo que evitaría las complicaciones en la adultez. Objetivo. Es evaluar el HOMA-IR, como indicador de riesgo de enfermedades endocrino-metabólicas en la población pediátrica con obesidad; así como mostrar sus limitaciones y utilidad diagnóstica. Método. Se realizó una revisión sistemática en las bases: Science Direct, Scopus, Scielo y Pubmed; utilizando los descriptores: “Índice HOMA-IR”, “Obesidad Infantil” y “Resistencia a la Insulina”. La búsqueda se restringió a artículos completos en español, inglés y portugués, entre 2007 y 2020. Se identificaron 3855 artículos, luego de aplicar las fases de análisis, se seleccionaron 10 artículos para la revisión, cada uno con puntos de corte específicos para la población estudiada y su respectiva curva ROC. Conclusión. Se concluyó que el HOMA-IR es un modelo confiable para el diagnóstico de IR temprana en niños, lo que permite una intervención terapéutica preventiva y diagnóstica, es un excelente predictor de enfermedades endocrino-metabólicas y complicaciones cardiovasculares futuras.


2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Tzu-Wen Cross ◽  
Evan Hutchison ◽  
Jacob Coulthurst ◽  
Federico Rey

Abstract Objectives Dietary fiber consumption improves cardiometabolic health, partly by enhancing microbial diversity and increasing production of butyrate in the distal gut. However, it is unclear whether the benefits associated with different types of fiber vary based on the gut microbiota composition. We surveyed nine different human gut microbial communities by characterizing them in germ-free mice and selected two communities based on their butyrate-producing capacity (“B”) and diversity (“D”) (i.e., high- vs. low-BD communities). Our objective was to assess the role of high- vs. low-BD communities on the metabolic effects elicited by the consumption of various dietary fibers. Methods We formulated seven diets with different sources of dietary fiber (10% wt/wt): i) resistant starch type 2 (RS2); ii) RS4; iii) inulin; iv) short-chain fructooligosaccharides (scFOS); v) pectin, vi) assorted fiber (a combination of the 5 fermentable fibers), and vii) cellulose (a non-fermentable control). Germ-free C57BL/6 male mice were colonized with either the high- or low-BD communities and fed the assorted fiber diet for 2 weeks to reach stability of microbial engraftment. Mice were then switched to one of the 7 diets for 4 weeks (n = 7–10/group; 117 mice total). We quantified cecal level of short-chain fatty acids and assessed the gut microbiota composition using 16S rRNA gene-based sequencing. Results Mice colonized with the high-BD community have lower body weight and fat mass compared to the low-BD community when fermentable-fiber sources RS2, inulin, or assorted fiber were present in the diet. Body weight did not differ between the two communities when mice were fed RS4, scFOS, pectin, or cellulose diets. Lower body weight and fat mass were associated with greater cecal butyrate concentrations and microbial diversity. Conclusions The efficacy of dietary fiber interventions on metabolic health varies based on the gut microbiota composition. Overall, our results suggest that dietary fiber supplementations need to be matched with the metabolic potential of the gut microbiome. Funding Sources Fondation Leducq, USDA, and NIH.


2010 ◽  
Vol 57 (7) ◽  
pp. 311-321 ◽  
Author(s):  
Eduardo Cabrera-Rode ◽  
Sigrid Marichal ◽  
Judith Parlá ◽  
Celeste Arranz ◽  
Roberto González ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document